Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

A team of scientists at the University of Michigan hopes to replicate the results in cells from diabetic patients and open ...

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

Drinking a tablespoon of apple cider vinegar diluted in a glass of water before meals can help improve insulin sensitivity ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...

Childhood cancer treatments, specifically total body irradiation, were associated with increased risk of developing diabetes among cancer survivors.

Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...